Skip Navigation



Carcinogenesis Advance Access published online on October 9, 2008

Carcinogenesis, doi:10.1093/carcin/bgn236
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
30/1/141    most recent
bgn236v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Oh, J.-M.
Right arrow Articles by Juhnn, Y.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oh, J.-M.
Right arrow Articles by Juhnn, Y.-S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells

Jung-Min Oh1, Su-Hyeong Kim1, Yun-Il Lee2, Miran Seo1, So-Young Kim1, Yong-Sang Song1,3, Woo-Ho Kim4 and Yong-Sung Juhnn1,2

1 Interdisciplinary Graduate Program in Tumor Biology, Cancer Research Institute
2 Department of Biochemistry and Molecular Biology
3 Department of Obstetrics and Gynecology
4 Department of Pathology, Seoul National University College of Medicine, Seoul 110-799, Korea

To whom correspondence should be addressed: Yong-Sung Juhnn, Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, 28 Yongon-dong, Jongno-gu, Seoul 110-799, Republic of Korea. Tel. 82-2-740-8247; FAX. 82-2-744-4534; E-mail. juhnn{at}snu.ac.kr

Human papillomavirus (HPV) is the major cause of uterine cervical cancer, but the role of the HPV E5 in carcinogenesis is not clearly understood. Prostaglandins are known to contribute to carcinogenesis of cervical cancer, and we therefore investigated the effect of HPV16 E5 on the expression of prostaglandin E2 (PGE2) receptors and underlying mechanisms. Stable expression of the E5 induced expression of the EP4 subtype of PGE2 receptors in C33A cervical cancer cells, and transfection of E5 siRNA decreased it. EP4 protein expression was increased in human cervical cancer tissues, and EP4 mediated E5-induced increase in anchorage-independent colony formation and VEGF expression. E5 induced COX-2 expression, and COX-2 increased PGE2 secretion and EP4 expression. The induction of EP4 by PGE2 and E5 was inhibited by an EP4 antagonist, inhibitors of cAMP dependent protein kinase or phosphatidylinositol 3-kinase, and a cAMP response element (CRE) decoy. E5 increased the luciferase expression controlled by a variant CRE of the EP4 promoter, and it also increased the binding of CREB to oligonucleotides containing this CRE. We conclude that the HPV16 E5 protein induces EP4 receptor protein in cervical cancer cells, and that this induction involves EGFR, COX-2, PGE2, EP2 and EP4, PKA, CREB, and CRE.

Key Words: human papillomavirus • E5 • EP4 • cyclic AMP response element • uterine cervical cancer

Received July 23, 2008; revised September 27, 2008; accepted September 28, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. L. Sagana, M. Yan, A. M. Cornett, J. L. Tsui, D. A. Stephenson, S. K. Huang, B. B. Moore, M. N. Ballinger, J. Melonakos, C. D. Kontos, et al.
Phosphatase and Tensin Homologue on Chromosome 10 (PTEN) Directs Prostaglandin E2-mediated Fibroblast Responses via Regulation of E Prostanoid 2 Receptor Expression
J. Biol. Chem., November 20, 2009; 284(47): 32264 - 32271.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.